{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:01:55Z","timestamp":1791298915420,"version":"4.1.0"},"reference-count":0,"publisher":"Ivyspring International Publisher","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cancer"],"published-print":{"date-parts":[[2013]]},"DOI":"10.7150\/jca.6083","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T03:43:44Z","timestamp":1367984624000},"page":"330-335","source":"Crossref","is-referenced-by-count":9,"title":["Modeling Efficacy of Bevacizumab Treatment for Metastatic Colon Cancer"],"prefix":"10.7150","volume":"4","author":[{"given":"Rezwan","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Huang","family":"Chyou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4137","container-title":["Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jcancer.org\/v04p0330.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:50:38Z","timestamp":1490575838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jcancer.org\/v04p0330.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.7150\/jca.6083","relation":{},"ISSN":["1837-9664"],"issn-type":[{"value":"1837-9664","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}